Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: dutton: we are raising our price target to $0.90 per share
Sorry, catching up on posts, and posted the same info about the 10Q before I read this.  Concur that Dutton is pretty weak.
Share
New Message
Please login to post a reply